News

PATH/Gabe Bienczycki
GHTC submits FY20 testimony to Senate appropriators

GHTC submitted written testimony to key Senate appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2020 (FY20) budget.

Learn More

PATH/Ruhani Kaur
GHTC endorses Comprehensive TB Elimination Act

GHTC joined other advocates in endorsing the Comprehensive TB Elimination Act of 2019, which would enhance tuberculosis (TB) R&D at the National Institutes of Health and facilitate coordination of late stage R&D of new TB diagnostic, treatment, and prevention tools with the Biomedical Advanced Research and Development Authority.

PDF

PATH/Nguyen Ba Quang
GHTC statement on High-Level Meeting on Tuberculosis (TB) delivered at WHA

A statement by GHTC and partners calling on the World Health Organization and member states to close the US$1.3 billion gap in annual TB R&D funding was made at the 72nd World Health Assembly. The statement urges countries to invest in the development of new medicines and technologies to treat multidrug-resistant TB and to facilitate rapid and equitable access to these interventions.

View

PATH/Gabe Bienczycki
GHTC statement on pandemic influenza preparedness delivered at WHA

A statement by GHTC and partners encouraging innovative technologies and approaches to accelerate universal influenza vaccine research and development was made at the 72nd World Health Assembly. This statement recognizes pandemic influenza as a looming global health threat and encourages the World Health Organization and member states to increase investment and collaborative action to accelerate development of a universal flu vaccine.

View

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide